Updated COVID-19 Statement, Oct 20


The Debrisoft® family

Preparing wounds to heal by simply removing barriers to healing

Order a sample

In detail

Designed with you and your patients in mind

The whole Debrisoft family benefits from patented monafilament fibre technology™.

Each tool has millions of fibres that are cleverly designed to lift, bind and remove barriers to healing.

Mechanical debridements most evidenced form of safe, effective debridement, even recommended by NICE.

Removes barriers to healing such as debris, slough, bacteria & biofilm all of which have an impact on exudate production and progression to healing.

Debrisoft Lolly

For cavity wounds and hard-to-reach areas of skin

Debrisoft Pad
(10 x 10cm)

For shallow wounds and accessible areas of skin

New - available on drug tariff

Debrisoft Pad
(13 x 20cm)

For larger wounds or areas of hyperkeratosis

Debrisoft gallery

See before and after images submitted by real clinicians using Debrisoft to treat their patients.

View gallery

Debrisoft is recommended for use by NICE


Indications for use:

  • Debridement of superficial, chronic and acute wounds and the skin surrounding the wound.
  • diabetic ulcers
  • arterial and venous ulcers
  • decubitus ulcers
  • postoperative wounds healing by secondary intention
  • traumatic or surgical wounds (e.g. abrasions, incisions, lacerations)
  • burns and scalds (3rd degree: following surgical debridement)
  • lymphoedema
  • Suitable for dry, parchment-like, hyperkeratotic, seborrhoeic or oily healthy or damaged skin.

Clinical evidence

A review of Debrisoft in the management of a variety of dermatological conditions

Debrisoft has recently had its clinical indication extended to include dermatological conditions such as eczema and psoriasis

Author: Lorenzelli D et al.
Publication: Dermatological Nursing, 2018, Vol 17, No 2
Date: June 26th, 2018


Debridement and wound bed preparation using Debrisoft® in a large lower limb haematoma

Debridement and wound bed preparation in the management of a haematoma should more often include the use of Debrisoft®, not just in patients who are not suitable for theatre and anaesthetic but to prevent where possible unnecessary, time consuming and expensive theatre and surgical time.

Author: Edel O’Neill, Tissue Viability Nurse,
Publication: Wounds UK Poster November 2017
Date: November 24th, 2017


Debrisoft Patient Leaflet

Debrisoft explained

Author: Activa
Publication: Activa Publication
Date: March 1st, 2012


Debrisoft:making the case

This guide is designed to be used to help make the case for implementing Debrisoft into clinical practice.

Author: Wounds UK
Publication: Wounds UK
Date: May 1st, 2015


Debrisoft:Revolutionising Debridement

Booklet with introduction from Kathryn and Peter Vowden. Case studies from a range of healthcare professionals including podiatrists.

Author: Activa supplement in BJN and BJCN
Publication: Journal Autumn 2011
Date: September 1st, 2011


Quick Guide - Debrisoft in Practice

This handy guide clearly shows you how and when to use Debrisoft, plus handy tips and hints on getting the best results. Debrisoft is supported by NICE and helps you assess and debride hyperkeratosis, acute and chronic wounds.

Author: Wounds UK
Publication: Wounds UK
Date: June 1st, 2014


Quick Guide: The Role of Debrisoft in Diabetic Foot Ulcers

Answers how Debrisoft can help manage diabetic foot ulcers and a useful decision making pathway

Author: Wounds UK and The Diabetic Foot Journal
Publication: Wounds UK and The Diabetic Foot Journal
Date: October 1st, 2014


The Debrisoft monafilament debridement pad for use in acute or chronic wounds

New NICE Guidance recommends the use of Debrisoft as part of the management of acute or chronic wounds in community settings. According to NICE, hundreds of thousands of patients with wounds requiring debridement could benefit from Debrisoft. Using Debrisoft on these patients could save the NHS in the region of £15 million annually.

Author: National Institute for Health and Care Excellence (NICE)
Publication: Medical technology guidance
Date: March 1st, 2014

View article

Using Debrisoft for Wound Debridement

Brief overview of methods of debridement and advantages of Debrisoft

Author: Maureen Benbow , Senior Lecturer, University of Chester
Publication: Journal of Community Nursing, Vol.25(5), Sept/Oct 2011
Date: September 1st, 2011


Ordering codes

Size (cm) Ref PIP code NPC code Bunzi Credenhill PECOS Item no. (Wales) Units per pack
Debrisoft Lolly
5 x 1.9 x 15.2
33224 398-5124 ELZ728 LH33224 - 215451 - 5
Debrisoft Pad
10 x 10
34321 358-1287 ELZ963 AL358-1287 31222 164271 ELC0281 5
Debrisoft Pad
13 x 20
34323 409-0351 ELZ964 - - - - 5
Available on Drug Tariff (FP10/GP10) in the uk

How to use

Debrisoft Pad


Debrisoft Lolly